Quitting New Jersey, betting on Macau
MGM Mirage's plan to exit the Atlantic City market in favor of booming Macau removes a year of overhang from the company and should clear the way for a share offering in Hong Kong by June. Full Article
Icahn ups stake in Biogen, says stock undervalued
WASHINGTON (Reuters) - Billionaire investor Carl Icahn reported on Monday that he owns a 6.03 percent stake in the common stock of biotechnology company Biogen Idec Inc (BIIB.O).
Icahn said in a filing with the U.S. Securities and Exchange Commission that he increased his stake "in the belief that the shares were undervalued."
He said his funds may acquire additional Biogen shares, debt or other equity. He also said his representatives may continue to have discussions with the company to "discuss general business issues relating to the issuer as well as their concerns relating to shareholder value."
(Reporting by Karey Wutkowski, editing by Leslie Gevirtz)












